Wu Licia N Y, Genge Brian R, Wuthier Roy E
Department of Chemistry and Biochemistry, Graduate Science Research Center, University of South Carolina, Columbia, South Carolina 29208, USA.
J Biol Chem. 2008 Feb 15;283(7):3827-38. doi: 10.1074/jbc.M707653200. Epub 2007 Dec 11.
The nucleational core of matrix vesicles contains a complex (CPLX) of phosphatidylserine (PS), Ca(2+), and inorganic phosphate (P(i)) that is important to both normal and pathological calcification. Factors required for PS-CPLX formation and nucleational activity were studied using in vitro model systems and molecular dynamic simulations. Ca(2+) levels required for and rates of PS-CPLX formation were monitored by light scattering at 340 nm, assessing changes in amount and particle size. Fourier transform infrared spectroscopy was used to explore changes in chemical structure and composition. Washing with pH 5 buffer was used to examine the role of amorphous calcium phosphate in CPLX nucleational activity, which was assessed by incubation in synthetic cartilage lymph with varied pH values. Addition of 4 Ca(2+)/PS was minimally required to form viable complexes. During the critical first 10-min reaction period, rapid reduction in particle size signaled changes in PS-CPLX structure. Fourier transform infrared spectroscopy revealed increasing mineral phosphate that became progressively deprotonated to PO(4)(3-). This Ca(2+)-mediated effect was mimicked in part by increasing the Ca(2+)/PS reaction ratio. Molecular dynamic simulations provided key insight into initial interactions between Ca(2+) and P(i) and the carboxyl, amino, and phosphodiester groups of PS. Deduced interatomic distances agreed closely with previous radial distribution function x-ray-absorption fine structure measurements, except for an elongated Ca(2+)-N distance, suggesting additional changes in atomic structure during the critical 10-min ripening period. These findings clarify the process of PS-CPLX formation, reveal details of its structure, and provide insight into its role as a nucleator of crystalline calcium phosphate mineral formation.
基质小泡的成核核心包含磷脂酰丝氨酸(PS)、钙离子(Ca(2+))和无机磷酸盐(P(i))的复合物(CPLX),这对正常和病理性钙化都很重要。使用体外模型系统和分子动力学模拟研究了PS-CPLX形成和成核活性所需的因素。通过在340 nm处的光散射监测PS-CPLX形成所需的Ca(2+)水平和形成速率,评估数量和粒径的变化。利用傅里叶变换红外光谱探索化学结构和组成的变化。用pH 5缓冲液洗涤用于检查无定形磷酸钙在CPLX成核活性中的作用,通过在不同pH值的合成软骨淋巴中孵育来评估。形成有活力的复合物最少需要添加4个Ca(2+)/PS。在关键的最初10分钟反应期内,粒径的快速减小表明PS-CPLX结构发生了变化。傅里叶变换红外光谱显示矿物磷酸盐增加,并逐渐去质子化为PO(4)(3-)。部分通过增加Ca(2+)/PS反应比例可模拟这种Ca(2+)介导的效应。分子动力学模拟为Ca(2+)与P(i)以及PS的羧基、氨基和磷酸二酯基团之间的初始相互作用提供了关键见解。推导的原子间距离与先前的径向分布函数X射线吸收精细结构测量结果密切一致,除了Ca(2+)-N距离延长,这表明在关键的10分钟成熟期中原子结构发生了额外变化。这些发现阐明了PS-CPLX的形成过程,揭示了其结构细节,并深入了解了其作为结晶磷酸钙矿物形成成核剂的作用。